Cargando…

Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity

Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportunities to mimic α-helical peptides and design inhibitors of protein-protein interactions. One major hurdle of this strategy is to retain the correct orientation of key side chains involved in protein s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbianda, Johanne, Bakail, May, André, Christophe, Moal, Gwenaëlle, Perrin, Marie E., Pinna, Guillaume, Guerois, Raphaël, Becher, Francois, Legrand, Pierre, Traoré, Seydou, Douat, Céline, Guichard, Gilles, Ochsenbein, Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978421/
https://www.ncbi.nlm.nih.gov/pubmed/33741589
http://dx.doi.org/10.1126/sciadv.abd9153
_version_ 1783667206131810304
author Mbianda, Johanne
Bakail, May
André, Christophe
Moal, Gwenaëlle
Perrin, Marie E.
Pinna, Guillaume
Guerois, Raphaël
Becher, Francois
Legrand, Pierre
Traoré, Seydou
Douat, Céline
Guichard, Gilles
Ochsenbein, Françoise
author_facet Mbianda, Johanne
Bakail, May
André, Christophe
Moal, Gwenaëlle
Perrin, Marie E.
Pinna, Guillaume
Guerois, Raphaël
Becher, Francois
Legrand, Pierre
Traoré, Seydou
Douat, Céline
Guichard, Gilles
Ochsenbein, Françoise
author_sort Mbianda, Johanne
collection PubMed
description Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportunities to mimic α-helical peptides and design inhibitors of protein-protein interactions. One major hurdle of this strategy is to retain the correct orientation of key side chains involved in protein surface recognition. Here, we show that the structural plasticity of a foldamer backbone may notably contribute to the required spatial adjustment for optimal interaction with the protein surface. By using oligoureas as α helix mimics, we designed a foldamer/peptide hybrid inhibitor of histone chaperone ASF1, a key regulator of chromatin dynamics. The crystal structure of its complex with ASF1 reveals a notable plasticity of the urea backbone, which adapts to the ASF1 surface to maintain the same binding interface. One additional benefit of generating ASF1 ligands with nonpeptide oligourea segments is the resistance to proteolysis in human plasma, which was highly improved compared to the cognate α-helical peptide.
format Online
Article
Text
id pubmed-7978421
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-79784212021-03-31 Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity Mbianda, Johanne Bakail, May André, Christophe Moal, Gwenaëlle Perrin, Marie E. Pinna, Guillaume Guerois, Raphaël Becher, Francois Legrand, Pierre Traoré, Seydou Douat, Céline Guichard, Gilles Ochsenbein, Françoise Sci Adv Research Articles Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportunities to mimic α-helical peptides and design inhibitors of protein-protein interactions. One major hurdle of this strategy is to retain the correct orientation of key side chains involved in protein surface recognition. Here, we show that the structural plasticity of a foldamer backbone may notably contribute to the required spatial adjustment for optimal interaction with the protein surface. By using oligoureas as α helix mimics, we designed a foldamer/peptide hybrid inhibitor of histone chaperone ASF1, a key regulator of chromatin dynamics. The crystal structure of its complex with ASF1 reveals a notable plasticity of the urea backbone, which adapts to the ASF1 surface to maintain the same binding interface. One additional benefit of generating ASF1 ligands with nonpeptide oligourea segments is the resistance to proteolysis in human plasma, which was highly improved compared to the cognate α-helical peptide. American Association for the Advancement of Science 2021-03-19 /pmc/articles/PMC7978421/ /pubmed/33741589 http://dx.doi.org/10.1126/sciadv.abd9153 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Mbianda, Johanne
Bakail, May
André, Christophe
Moal, Gwenaëlle
Perrin, Marie E.
Pinna, Guillaume
Guerois, Raphaël
Becher, Francois
Legrand, Pierre
Traoré, Seydou
Douat, Céline
Guichard, Gilles
Ochsenbein, Françoise
Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
title Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
title_full Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
title_fullStr Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
title_full_unstemmed Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
title_short Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
title_sort optimal anchoring of a foldamer inhibitor of asf1 histone chaperone through backbone plasticity
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978421/
https://www.ncbi.nlm.nih.gov/pubmed/33741589
http://dx.doi.org/10.1126/sciadv.abd9153
work_keys_str_mv AT mbiandajohanne optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT bakailmay optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT andrechristophe optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT moalgwenaelle optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT perrinmariee optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT pinnaguillaume optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT gueroisraphael optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT becherfrancois optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT legrandpierre optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT traoreseydou optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT douatceline optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT guichardgilles optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity
AT ochsenbeinfrancoise optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity